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Abstract
The use and abuse of alcohol and nicotine are intimately related, with co-use of alcohol among
adult cigarette smokers higher (>65%) than non-smokers (>45%), and smoking rates among
alcoholics above 75%. Smoking is associated with an accelerated progression to alcohol
dependence, suggesting that nicotine and alcohol act in a synergistic manner to promote coabuse. While recent work has begun to identify discrete ‘neuronal ensembles’ within stress and
reward circuitry components that underlie nicotine’s contribution to escalations in alcohol selfadministration, the neurobiological mechanisms facilitating alcohol-nicotine interactions
following chronic drug exposure remain understudied. The goal of the current work was to
identify a network of brain regions in mice that are activated differentially following chronic
intermittent exposure to alcohol versus alcohol plus nicotine combinations via c-Fos
immunoreactivity. Male C57BL/6J mice were systemically treated with either alcohol (1.5 g/kg)
or a combination of alcohol plus nicotine (0.4, 0.8, or 1.2 mg/kg base) on a double-alternation
schedule (drug, drug, saline, saline) for a 13-month period. Mice were euthanized 90-min
following the final treatment, whole brains were removed and 40-µm coronal sections were
evaluated for c-Fos immunoreactivity using established laboratory procedures. Co-administration
of 0.4 and 0.8 mg/kg nicotine dose-dependently enhanced c-Fos immunoreactivity in the ventral
tegmental area (VTA), centrally projecting Edinger-Westphal nucleus (cpEW), and the lateral
septum (LS) when compared to alcohol only treated mice. In contrast, co-administration of 1.2
mg/kg resulted in a 33% decline in c-Fos labeled cells within the VTA, no change in LS
activation, and comparable activation to 0.4 mg/kg nicotine in the cpEW. In summary, chronic
intermittent nicotine exposure exacerbates the c-Fos response to alcohol in a dose-dependent and
brain region-selective fashion. The nearly uniform, maximal response observed following 0.8
mg/kg nicotine across stress- and reward-associated brain regions is consistent with the ability of
this dose to accelerate the progression towards excessive alcohol self-administration and to
potentiate the discriminative stimulus effects of alcohol in rodents.

-Dedicated to my Dad -
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Introduction
Alcohol & Nicotine
The use of Alcohol and Tobacco products has become a major public health
concern in recent years. Nicotine specifically is the primary component in tobacco
products that leads to drug dependence and reward. Alcohol and nicotine have
pharmacological and neurological synergistic effects, resulting in various health problems
such as cancers, vascular diseases, and gastric ulcers (Hurley, Taylor, & Tizabi, 2012).
Widespread legalization and abundant availability plays a role in these most commonly
abused substances, but genetic, rewarding, and analgesic properties of alcohol and
nicotine also add to massive levels of use among the public. Alcohol and nicotine are
often used simultaneously, especially among alcoholics, where smoking rates are
estimated to be about twice as much as the general population in both adolescents and
adults (Falk, Yi, & Hiller-Sturmhöfel, 2006). This is a growing concern because
traditional addiction research has only set out to study the effects of alcohol and nicotine
separate from one another. This approach to addiction research does not accurately
represent the way in which alcoholics and smokers consume these substances. In turn,
the use of alcohol among adult cigarette smokers is relatively high (65.2%) compared to
non-smokers (48.7%) (CDC, 2013). Acute nicotine administration has also been shown to
increase alcohol self-administration in non-dependent smokers, suggesting that nicotine
dose can effect alcohol’s interaction with the brain early in the process of addiction
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(Barrett, Tichauer, Leyton, & Pihl, 2006). The current research aims to address the
question of how chronic, long term exposure, to alcohol and nicotine may influence the
way these drugs are taken over time by creating a novel set of ‘neuronal ensembles’ that
utilize previously associated mechanisms of addiction. With these questions in mind,
knowing how various dosing levels of nicotine react with a consistent dose of alcohol can
aid in finding the neurological mechanisms underlying co-abuse. Nicotine seems to prime
the reward and stress system for alcohol, resulting in a greater amount of alcohol
administration, and produces long lasting changes to signaling pathways (Doyon et al.,
2013). It is currently unclear as to how co-morbidity arises from the interaction of these
two drugs, but further exploration of nicotine addiction can help reveal many aspects of
drug dependence, especially in adolescents and people with mental illness, who are at
higher risk for co-morbidity (Dani & Harris, 2005). As a way to incorporate running
hypotheses within the field of addiction research, the involvement of stress hormones and
associated stress-hormone releasing structures within the brain are included in the
analysis of ‘neuronal ensembles’, but it is still under investigation as to how exactly these
stress pathways are influencing the neurology and behaviors of addiction. Stress-related
hormones have been found to have lasting changes in dopamine and GABA
neurotransmission, which are active components of the reward pathway (Walker et al.,
2012). GABA acts primarily as an inhibitory neurotransmitter, with activation typically
causing a decrease in neuronal excitability in the central nervous system (CNS), with
notable building evidence to a possible link between the GABA type A (GABAA)
receptor and the genetic component of alcoholism (Davies, 2003). Alcohol acts partially
on the GABAA receptors to enhance receptor activity and increasing the amount of
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GABA available. Dopamine, on the other hand, is associated with all drugs of abuse and
is commonly associated by researchers with wanting, learning, and reward. The
relationship between dopamine and other neurotransmitters, especially GABA, is vital to
understanding the way in which these networks of addiction and reward operate. The
receptors where nicotine act in the brain are thought to be primarily nicotinic
acetylcholine receptors (nAChRs), and are involved in both the mediation of alcohol and
the cause of behavioral changes in nicotine (Bito-Onon, Simms, Chatterjee, Holgate, &
Bartlett, 2011). nAChRs are found in many areas in the brain, including those related to
reward and stress (Ventral Tegmental Area, Substantia Nigra, Striatum, Hypothalamus).
Exploration of the basic mechanisms involved in co-abuse are needed before it can be
fully understood as to how these neurotransmitters, receptors, and pathways are
interacting with alcohol and nicotine. By studying the overlapping actions of alcohol and
nicotine, valuable information about the co-abuse of many drugs of addiction can be
revealed. These efforts lay down the groundwork for further research not only in the field
of addiction, but for any study of neurological interactions and mechanisms. This
approach can effectively narrow the direction of how treatments are used and made
accessible for public use.

Animal Model of Co-Abuse
As a way of addressing issues in studying co-abuse, neurological activity must be
examined to reveal specific areas of the brain that are most active when alcohol and
nicotine are present. Although substance abuse is a human concern, using a suitable
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animal model can provide valuable behavioral and neurological data on alcohol-nicotine
interactions. It is unlikely that an exact representation of the complexity of human
addiction can be reached using the animal model alone, but specific aspects can be
revealed such as drug self administration, tolerance, sensitivity, and withdrawal (Balogh,
Owens, Butt, Wehner, & Collins, 2002). Procedures of self-administration have shown
that rats will continually consume significant amounts of both alcohol and nicotine when
made available, with levels of nicotine self-administration similar to rates of nicotine
alone (Lê et al., 2010). This research supports the important relationship between the two
drugs, and the need to use animal models to ask basic questions about how are
interacting. Animal models can be used as a way to address questions that both fully
utilize the particular model and maximize results for comparison and analysis.

Mechanisms of Addiction
Abused drugs act on a series of neurological mechanisms within the brain,
specifically the reward system. All individuals use the reward system every day for many
aspects of life including eating, drinking, sex, and social engagement. The reinforcement
of behaviors that are beneficial for survival are pleasurable to us because of the function
of the reward system. We continue to partake in these activities because the neurological
pathways are strengthened after each interaction, establishing a memory of reward. Drugs
of addiction utilize the same reward pathways to alter an individual’s natural drive
towards drug seeking behaviors. Because the brain is communicating via electrical and
chemical signaling, drugs can change the way in which this signaling process happens, by
either strengthening or weakening the communication between neurons. The chemical
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signal used by neurons are called neurotransmitters, and when released, bind to receptors
that activate a cascade of cellular activity. Dopamine (DA) is the key neurotransmitter
involved in the reward system, but GABA, glutamate, and serotonin among others are
also involved. DAergic neurons project from the VTA and midbrain structures to limbic
and cortical areas, including the Nucleus Accumbens and the Prefrontal Cortex when
activated by pleasurable stimuli. When dopamine is released in the form of a chemical
message, it either binds to receptors or is taken back up through transporters reuse. Drugs
of addiction, such as alcohol and nicotine, indirectly excite the neurons that produce
dopamine in the VTA to generate a greater amount of dopamine release within the
synapse. The repeated pulse of dopamine receptor activation will de-sensitize the reward
system over time, which decreases the normal dopamine response to healthy and
everyday rewarding activities. When drugs are used often over a long period of time, as
with chronic drug users, the brain begins to adapt to these changes. A patterned response
is then established, which is referred to as neuroadaptation. The response from the brain
is a developed tolerance, where the same doses of the drug no longer produce the same
effect and larger doses are needed to get the desired gratification. Drugs of addiction will
quickly rise to a top priority for users with a compromised reward system, because these
drugs give greater pleasure than other activities. Over time, the dopamine receptors will
become overstimulated and stop responding to the previous dose of the drug, which
eventually leads to permanent damages to the way the brain functions in everyday
activity.
The stress system adds an additional feature to the way drugs are delivering the
experience of reward and pleasure. The hypothalamic-pituitary-adrenal (HPA) axis is
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activated when our body naturally reacts to stress. The hypothalamus is a small structure
that regulates the release of hormones from the pituitary gland. The release of hormones
from the pituitary gland travel down the bloodstream to the kidneys and interact with the
adrenal glands. The regulation of the stress response begins at the hypothalamus, where a
hormone called corticotropin-releasing hormone (CRH) is released. CRH signals to the
pituitary gland to secrete adrenocorticotropic hormone (ACTH) into the bloodstream,
which travels down to the adrenal glands and signals the release of different steroid
hormones depending on the site of activation. A class of hormones released from the
outer (cortical) layer of the adrenal glands are called glucocorticoids, specifically cortisol,
and they play and important role in stress, which increase blood sugar, suppress the
immune system, and aid metabolism. ACTH also acts on the adrenal medulla (center of
the adrenal gland) to trigger the release of epinephrine and norepinephrine, thereby
increasing heart rate and alertness. Elevated cortisol levels in the bloodstream are sensed
by glucocorticoid receptors in the hypothalamus that initiate a negative feedback
response to counteract the stress response. This regulation via negative feedback allows
for the regulation of cortisol to maintained at appropriate levels. Glucocorticoid receptors
are also found in the midbrain, striatum, and cortical areas important for reward. It has
been suggested that a nicotine and alcohol combination alters stress hormones in the early
stages of drug intake and prime the system for negative emotional states, which are
described as withdrawal (George F. Koob et al., 2014). This further supports the idea that
having a nicotine addiction (i.e. smoking cigarettes) can make a person more susceptible
to drinking high amounts of alcohol.
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Neural Circuitry Underlying Alcohol and Nicotine Effects
Alcohol (or ethanol specifically) is a dynamic drug that reacts with several brain
functions. Generally, alcohol is known as a depressant that inhibits brain activity in the
CNS. Alcohol interacts with GABA-A receptors to gate the amount of negatively charged
ions (i.e., chloride) that are let into the cell. Chloride acts to inhibit the excitability of the
neuron by causing hyperpolarization. For drinkers of alcohol, results of the interaction
with GABA-A receptors produce calming and anxiolytic effects at low doses, but
negative effects impair judgement and disrupt motor functions at higher doses. NMDA
(glutamate) receptors, which are associated with the excitability of the neuron, are
inhibited by alcohol by blocking the gating of sodium (Na+) and calcium (Ca+2) into
cells. Nicotine is a psychostimulant that acts on acetylcholine receptors (nAChRs) to
depolarize the neuron and increase excitability. Within the sympathetic nervous system
nicotine increases blood pressure, heart rate, and the release of norepinephrine. Cigarette
smokers experience effects of calmness, alertness, relaxation, but negative symptoms of
craving, irritability, and impatience.
When these drugs are taken together, both biological and behavioral effects are
altered. The complex phenotypes that are observed in addicted individuals vary
depending on the drug(s) of choice, resulting in different neurological changes within
these circuits. Although neuronal activation following alcohol or nicotine can be
observed separately, the combination of the two drugs likely alters the way these
pathways would function during single drug use (for instance, synergism or additivity) or
involves activation of new pathways in the brain. To begin to understand how alcohol
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and nicotine are interacting we must gain a perspective on previous addiction studies,
findings, and definitions. A commonly accepted addiction model describes three
progressive stages of the addiction that involve binge, withdrawal, and craving (G. F.
Koob, 1997). These stages have been associated with discrete circuits that incorporate
specific neuronal structures that describe how theories of addiction can be applied to a
variety of drugs. Ventral tegmental area (VTA) and ventral striatum are associated with
binge, amygdala with withdrawal, and prefrontal cortex, basolateral amygdala,
hippocampus, and insula with craving (G F Koob & Volkow, 2010). Response to chronic
exposure tends to be more restricted within certain brain regions in the case of alcohol.
On the other hand, consistent response from both chronic and acute treatments of alcohol
are seen from lateral septum, edinger-westphal nucleus, and paraventricular nucleus of
the hypothalamus (Vilpoux, Warnault, Pierrefiche, Daoust, & Naassila, 2009). The use of
mecamylamine (nACh-R antagonist) or other ligands that bind to receptors activated by
alcohol or nicotine may allow for a clear view of what types of activity are happening
with or without this substance. Nicotine speeds up the process of alcohol drinking in
dependent rats, recruiting a number of neuronal structures including VTA and
dorsomedial prefrontal cortex, blocking nicotinic receptors with mecamylamine (noncompetitive antagonist of nAChRs), effectively blocking behavioral and neuronal effects
(Leão et al., 2015). Drugs that replace the effects of alcohol or nicotine can help to
determine what each substance is acting on receptors and interacting with each other. The
influence of nAChR antagonist mecamylamine has been examined within operant selfadministration in C57BL/6J mice, and found a suppression in dose-dependent alcohol
intake and change in locomotor activity (Ford et al., 2009). Although more experiments
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using drug substitutions still need to take place, the previous findings suggest that a map
of the way in which nAChRs and neuronal activity function with the combination of
alcohol and nicotine would be of valuable importance for addiction research.

c-Fos
C-Fos is the cellular counterpart to a viral gene isolated in 1982 from FinkelBiskis-Jinkus osteogenic sarcoma virus, and is defined as a type of immediate-early gene
(IEG) that rapidly responds to intracellular signaling (Sng, Taniura, & Yoneda, 2004).
IEGs have been an important focus of the field of addiction research for over 20 years
because administering drugs of addiction (chronic or acute) changes IEG expression,
which can be used to measure the processes of addiction in a way that identifies druginduced neuroplastic changes (Kalivas et al., 2006). Positive c-Fos activation has been
identified using immunocytochemistry to reveal effects of nicotine on brain regions
related to stress, suggesting they could be mediating the effects of nicotine on the central
nervous system (CNS) (Matta, Valentine, & Sharp, 1997). C-Fos can be stained in the
brain by using an antibody to reveal the regions activated prior to mice being euthanized.
We would expect the traditional reward and stress regions to be active, but c-Fos can
reveal new areas of activation and significant suppression or expression differences in
varied doses.
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Research Question
How does chronic intermittent administration of alcohol and alcohol-nicotine
combinations change the amount of brain activation in the male C57BL/6J mouse brain?

Hypothesis
It was hypothesized that the combined effects of alcohol and nicotine would
produce brain activation in stress and reward related areas, with the combined alcoholnicotine dosing (fixed alcohol dose plus low, medium or high dose nicotine) showing a
difference in activation compared to the saline or alcohol only control groups.
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Methods
C57BL/6J (B6) mice were acquired from the Jackson Laboratory-West
(Sacramento, CA, USA) for the drug discrimination (behavioral) portion of this study
(beyond the scope of this thesis; data not shown). All the mice were male, and double
housed in standard laboratory cages. Lights were turned on from 6am-6pm each day to
regulate sleep cycles. The mice were given food, and maintained at 90% of their freefeeding body weights. Water was freely available. The Institutional Animal Care and Use
Committee (IACUC) approved all procedures with the animals in accordance with state
and federal guidelines. IACUC members are made up of qualified and experienced
experts that oversee animal programs, facilities, and procedures (Ford, McCracken,
Davis, Ryabinin, & Grant, 2012).

Dosing & Treatment
Mice groups were administered a fixed alcohol dose (1.5 g/kg) or one of three
combinations of alcohol + nicotine. Treatment groups were as follows: 1.5 g/kg alcohol
(1.5E) alone, 1.5 g/kg alcohol + 0.4 mg/kg nicotine (1.5E + 0.4N), 1.5 g/kg + 0.8 mg/kg
nicotine (1.5E + 0.8 N), and 1.5 g/kg alcohol + 1.2 mg/kg nicotine (1.5E + 1.2N). Fixed
ratio schedule (FR) was used as a form of operant conditioning that provided
reinforcement after a specified number of responses. Once the mice were trained, the
mice were divided into separate groups and given an intraperitoneal (i.p.) injection of
either the saline, alcohol, or nicotine-alcohol combination (Ford et al., 2012). A double-
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alternation schedule of drug administration was used where saline (i.e., non-drug) was
given two days in a row and then alcohol or both drugs for two days (saline, saline, drug,
drug). Each group of mice were required to meet criteria for drug discrimination for three
days prior to and including the final testing session, the last requirement that the mice
needed to demonstrate criteria on the test session that day in order to be euthanized (see
Ford et al., 2012 for additional details). To avoid disruptions in home cage environments,
both mice (housed in pairs) were required to meet criteria on the same day. Each group
(n=12) was divided into sub-groups (n=6) that were balanced with a four day mean
according to total responses from both levers (activity measure), initial FR accuracy (%
appropriate responding), and body weight (training sessions only; test sessions not
included). The time of day, handling, and transportation were all taken in to consideration
during the procedure for final testing, as to not disrupt normal occurrences in the home
cage. Individual mice were injected with treatment dose according to sub-group and
placed into the operant chamber for 10-min pretreatment. Following pretreatment, the
house light turning on and the test session began for the standard 15 min sessions. The
mice were then returned to their home cage and fed their daily food diet, and remained in
the procedural room for another 55 min before being transported to a separate procedural
room where they were placed in a CO2 chamber. At 90 min total after initial treatment
injection mice were euthanized (Ford et al., 2012). Normally, a perfusion of
paraformaldehyde (PFA) is used to preserve the tissue and organs of the mouse, but in
this particular procedure PFA was not used because it can prevent the primary antibody
(c-Fos) from binding properly. The whole brain was isolated in a time sensitive manner
(about 12ml of fixative tissue) and placed into a cold a 2% paraformaldehyde buffer. The
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brains can then be cryoprotected and stored for up to year or more. When brains are ready
to be sliced they are placed on a fixative mount, covered with a thin layer of Optimal
Cutting Medium (OCT), and frozen before being cut into slices 30-40 microns thick.
After the slices are placed into net wells they are stained with the primary antibody (cFos), washed, and dried before coverslipping with cryoseal (Ryabinin, Criado, Henriksen,
Bloom, & Wilson, 1997). The final product of this procedure allows for the stained brain
slices to be viewed under a microscope for comparison and analysis.

Imaging & Counting Cells
An initial global examination of the mouse brain slides was taken using a light
microscope and a mouse brain atlas. This allowed for an unbiased look at c-Fos
activation throughout different sections of the brain. Certain areas with staining that
could be seen easily with the naked eye stuck out immediately, but it was still difficult to
get an accurate count of cell activation (ranging from 10-2000 cells) along with having a
way to to detect the variations in size, shape, and clarity of the stained cells. The
traditional method for counting cells, done by hand, would not provide a reliable count of
the cells that were stained on each slide and because some sections contained thousands
of cells, we needed an accurate way to measure and analyze these cell populations for
statistical comparison. To best examine each brain slice, digitalized each of the slices
using a light microscope and a camera (mounted on top).
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Figure 1: Light Microscope with Mounted Camera
The camera itself was hooked up to a computer monitor for live viewing of the
microscope slides. This provided an accurate way to see how the image would turn out
before taking the shot. The camera settings were kept consistent to preserve uniformity
between images.

This proved to aid in the clarity of the staining along with providing the ability to
use additional analysis programs. With the help of Andrey Ryabinin’s lab at OHSU
Marquam Hill we were able to get a series of images from the following brain regions
including: Lateral Septum (LS), Edinger-Westphal Nucleus (EW), Substantia Nigra
(SN)(Bi-Lateral), Nucleus Accumbens (NuAcc)(Bi-Lateral), and Ventral Tegmental Area
(VTA)(Bi-Lateral) (OHSU, n.d.). Beginning with each brain region, settings on the light
microscope and mounted camera were kept at consistent settings, with a background
image of blank light taken at the start of each session. The background image would later
be subtracted from the brain image to reduce any excess light and allow for a clearer view
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of the staining. The regions of interest (ROIs) were imaged and organized by mouse
number and slide. To keep the images consistent across regions the light microscope
would be rented out for 4-8 hours at a time to capture the entire selection. For the
analysis, ImageJ was used, an open-source java-based processing program developed at
the National Institutes of Health (NIH) to provide the architecture to create a procedure
for counting c-Fos cells (ImageJ, n.d.) Each image was properly rotated and examined for
any obstructive light, dirt, or user interference.

Figure 2: Region of Interest (ROI) ImageJ
The region above (EW) is an un-edited zoomed-in captured image (10x) of a mouse brain
slice. Because each slice image needed to be consistent, none of the slides were edited for
contrast or acuity. This required a great deal of attention to the way in which each image
was captured.
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The background image and the ROI image was opened in ImageJ, and the
background was subtracted. A new black and white ROI image was then generated to
allow for a noise free analysis of the stained cells.

Figure 3: Subtracted Background Black and White ImageJ
The purpose of subtracting the background allows for a clear view of the tissue only
without the noise of the ambient light from the microscope, The black and white image
allows for a greater contrast to help reveal the stained cell bodies.

The threshold tool within ImageJ was adjusted to fill up of the cell bodies, and a
standard threshold criteria was established (10-110 pixels^2).
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Figure 4: Threshold ImageJ
The threshold acts as a mask on top of the subtracted background image. The red
selections can be adjusted until only stained cell bodies are highlighted. During the
analysis portion the perimeters for each cell size is set to exclude any particles too large
or small to be a cell.

A free hand selection method and a mouse brain atlas was used to select the ROI
within the image to adjust for the size variance between brain slices and regions. After
selecting the ROI, everything outside the selection was cleared and an analysis of the cell
particles were run using ImageJ tools.
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Figure 5: Hand-tool Selection ImageJ
The mouse brain atlas (Paxinos and Franklin’s 4th Edition) was used to identify the brain
region stained was consistent with the ROI before making a hand drawn selection around
the area. Everything outside the selected region is then cleared to make sure outside
particles are not picked up in the cell count analysis.

A summary of the cell counts, total region area, and average cell size was
generated for each slice (3-6 slices per mouse). Statistical data was analyzed using two
way ANOVA to compare 0.4N, 0.8N, and 1.2N doses to the ethanol only treated group
and comparisons between individual groups. Averages were obtained by combining all
slice counts from each mouse (n=5-6 mice per group).
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Results

A

B
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C

D

Co-administration of 0.4 and 0.8 mg/kg nicotine dose-dependently enhanced c-Fos
immunoreactivity in the ventral tegmental area (VTA) compared to the ethanol only
group (Graph A). The VTA is a bilateral structure that was imaged and analyzed on the
left and right side separately to check for any variance between the two sides, but none
was found. The centrally projecting Edinger-Westphal nucleus (cpEW) (Graph B), and
the lateral septum (LS) (Graph C) when compared to alcohol only treated mice also
displayed an enhanced level of c-Fos activation among the 0.4 and 0.8 mg/kg nicotine
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groups. The 0.4N and 0.8N groups seem to provide the most dynamic activation among
the treatment groups, leading to the possibility of using these groups for further studies of
stress and reward. In contrast, co-administration of 1.2 mg/kg resulted in a 33% decline
in c-Fos labeled cells within the VTA, no change in LS activation, and comparable
activation to 0.4 mg/kg nicotine in the cpEW. These high levels of nicotine may be
overstimulating the cells in each region, but without knowing which cells in particular are
activating (i.e neurons vs glia) it is difficult to conclude anything from these decreased
levels of activation. Chronic intermittent nicotine exposure is altering the c-Fos response
to alcohol in a dose-dependent and brain region-selective fashion, but these results only
indicate general cellular activation within the specified regions. To look in more detail at
the types of cellular activation taking place in these regions we would need to label for
cell types and receptors that interact with alcohol and nicotine specifically. The nearly
uniform, maximal response observed following 0.8 mg/kg nicotine across stress- and
reward-associated brain regions such as the NucAcc (Graph D) is consistent with the
ability of this dose to accelerate the progression towards excessive alcohol selfadministration and to potentiate the discriminative stimulus effects of alcohol in rodents.
Low statistical power (n=5-6 mice per group) in this study compared with other studies
using higher populations of mice (8-12 mice per group) can contribute to the lack of
significant changes of activation between groups.

Conclusions
Addiction research has come a long way in recent years, with new methods and
approaches being developed constantly. As we gain a basic understanding of the
neurobiology of addiction, new questions arise at every turn. Polysubstance abuse,
particularly the interactions of alcohol and nicotine have major gaps that must be
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addressed by the scientific community. There is an obvious social concern with rates of
comorbidity as high as 92% in people with alcohol use disorders (AUDs) (Gold, 1998).
The main pharmacotherapeutic strategies do not reflect the way in which drugs are used
in our society today, but focus on reducing either alcohol or nicotine use separately.
None of these individual pharmacological options have proven to have the wide success
that in needed to have any significant impact. People use drugs of abuse for a large
variety of reasons and therapies should have a similar kind of a approach to essentially
tailor to individual needs. The current research has aimed to model a chronic user of both
alcohol and nicotine. Because of this, subpopulations of drug users at different stages of
addiction may have an entirely different set of effects, as would be expected. Although
recognizing the way in which a chronic user is functions can help identifying the discrete
‘neuronal ensembles’ of activation to seek out and observe in the future. The types of
activation found in this study has shown a wide variety of regions that are incorporated
when both alcohol and nicotine are present, but this could lead to a specific narrative that
can be linked together. In addition to using knowledge of the reward system recent work
has incorporated the stress system to aid in piecing together the mechanisms in
facilitating the escalation of alcohol drinking with chronic nicotine users (Leão et al.,
2015). With more researchers asking new questions and conducting alternative methods
to studying addiction the sense of breaking through the barriers of past approaches and
finding useful therapeutic treatments is that much closer to realization.
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